SCINTOMICS
LIVE

Serial Number

79097099

Owner

Scintomics GmbH

Attorney

Marta L. Paul

Filing Date

Feb 21, 2011

Add to watchlist:

No watchlists yet
View on USPTO

SCINTOMICS Trademark

Serial Number: 79097099 • Registration: 4398176

SCINTOMICS is a trademark filed by Scintomics GmbH on February 21, 2011. The trademark is classified under Class 9 (Computers & Electronics). The application is currently registered and active.

Owner Contact Info

Scintomics GmbH

Lindach 4

Entity Type: 16

Trademark Details

Filing Date

February 21, 2011

Registration Date

September 10, 2013

Published for Opposition

June 25, 2013

Cancellation Date

February 21, 2021

Goods & Services

[ Scientific, nautical, surveying, photographic, cinematographic, optical, weighing, measuring, signaling, checking, supervising, life-saving and teaching apparatus and instruments, namely, automated apparatus and analytical instruments in the nature of computers, microscopes, scanners; computer software for production, handling, dispensing and analysis of radiopharmaceuticals, radioactive contrast agents and precursors thereof as molecular imaging agents and endoradiopharmaceuticals for preclinical, clinical, medical, veterinary, and in vivo and in vitro use and research; video screens, spectrometers, dispensers of preset portions of fluids for dosing purposes and not for medical use; radioisotopic labeling machines for use in radiopharmaceutical technology, namely, machines for chemical introduction of radiolabelled isotopes into molecules resulting in a radiopharmaceutical for the purification and the final sterile filtration of the aforementioned radiopharmaceutical; electrical control devices for all the afore-said goods; ] modules for the production of Ga-labelled peptides, synthesizers, namely, synthesizers for the automated Ga-labelling of peptides, for radiolabelling, isotope purification, routine tracer production and other radiopharmaceutical processes, modules for the production of Ga-labelled peptides; [ synthesizers, namely, synthezizers for the automated radiolabelling of pharmaceuticals, for isotope purification, routine tracer production and other radiopharmaceutical processes; tracer production platforms, namely, laboratory equipment for production, dispensing, handling and analysis of radioactive chemicals, compounds and pharmaceuticals, namely, synthesizers, cassettes, dispensers, quality control apparatus therefor in the form of a thin layer radio chromatography and/or a high performance liquid radiochromatography as quality control apparatus; sensing and signaling devices for controlling the quality of synthesized radiopharmaceuticals; compact radiosynthesis platforms, namely, laboratory equipment for production, dispensing, handling and analysis of radioactive chemicals, compounds and pharmaceuticals, namely, synthesizers, cassettes, dispensers, quality control apparatus therefor in the form of a thin layer radio chromatography and/or a high performance liquid radiochromatography as quality control apparatus; sensing and signaling devices for controlling the quality of synthesized radiopharmaceuticals; ] automated modules for the dispensing of radiopharmaceuticals for laboratory use; [ computer software for facilitating gmp report generators and the editing of labels; control interfaces, namely, electronic display interfaces, motor syringes, namely, disposable reusable dispenser syringes for laboratory use; ] vario Tec-based modules and fully automated four capillary reactor microfluidic modules in the nature of computer hardware; fully automated dispensing units for single dose dispensing into vials or syringes for laboratory use; [ medical laboratory machines, namely, radiopharmaceutical synthesizing machines comprised of a series of valves, tubing, and reaction vials used to make radioisotope drugs; medical apparatus for preparing hazardous drugs, namely, radioactive injectables consisting of a medical robot designed to assist personnel in preparing drugs in radiopharmacies, radioactive laboratories, or in hospital settings, all the aforementioned goods used for the production, handling, dispensing and analysis of radiopharmaceuticals, radioactive contrast agents and precursors thereof as molecular imaging agents and endoradiotherapeuticals for preclinical, clinical, medical, veterinary and in vivo and in vitro use and research; apparatus and instruments for the conducting, switching, transforming, accumulating, regulating and controlling of data in the nature of flow meters, [ conductivity meters, ] calibration devices for calibrating the dosing of radioactive radiation not for medical use, calibration devices for calibrating optical emission spectrometers, atomic absorption spectrometers and X-ray apparatus, other than for medical use; all of the aforementioned goods used for the production, handling, dispensing and analysis of radiopharmaceuticals, radioactive contrast agents and precursors thereof as molecular imaging agents and endoradiotherapeuticals for preclinical, clinical, medical, veterinary and in vivo and in vitro use and research; apparatus for recording, transmission or reproduction of sound or images; blank magnetic data carriers, data processing equipment and computers; computer software for use in the control and monitoring of automated process for the production, handling, dispensing and analysis of radiopharmaceuticals, radioactive contrast agents and precursors thereof as molecular imaging agents and endoradiotherapeuticals for preclinical, clinical, medical, veterinary and in vivo and in vitro use and research; computer hardware and electronic computer hardware components ]

Filing History

NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG E-MAILED
Nov 13, 2021 DENC
DEATH OF INTERNATIONAL REGISTRATION
Nov 13, 2021 DETH
IRREGULARITY ON INVALIDATION RECEIVED FROM IB
Apr 6, 2021 IRIV
PARTIAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
Mar 19, 2021 INPS
INVALIDATION PROCESSED
Mar 19, 2021 INPC
PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED
Mar 14, 2021 INPR
NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED
Jul 14, 2020 NA71
REGISTERED-SEC.71 ACCEPTED
Jul 14, 2020 71AG
TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED
Jun 30, 2020 EROP
POST REGISTRATION ACTION MAILED - SEC.71
Apr 28, 2020 PR71
TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED
Mar 11, 2020 EROP
POST REGISTRATION ACTION MAILED - SEC.71
Sep 11, 2019 PR71
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Sep 11, 2019 APRE
TEAS SECTION 71 RECEIVED
Sep 5, 2019 ES71
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
Sep 10, 2018 REM3
NEW REPRESENTATIVE AT IB RECEIVED
May 31, 2015 NREP
FINAL DECISION TRANSACTION PROCESSED BY IB
Dec 30, 2013 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Dec 11, 2013 FICS
FINAL DISPOSITION PROCESSED
Dec 11, 2013 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Dec 10, 2013 FICR
REGISTERED-PRINCIPAL REGISTER
Sep 10, 2013 R.PR
NOTIFICATION PROCESSED BY IB
Aug 17, 2013 GPNX
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jun 25, 2013 NPUB
PUBLISHED FOR OPPOSITION
Jun 25, 2013 PUBO
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Jun 5, 2013 OPNS
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Jun 5, 2013 OP2R
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jun 5, 2013 NONP
LAW OFFICE PUBLICATION REVIEW COMPLETED
May 20, 2013 PREV
EXPARTE APPEAL TERMINATED
May 19, 2013 EXPT
APPROVED FOR PUB - PRINCIPAL REGISTER
May 17, 2013 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Mar 21, 2013 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Mar 21, 2013 CRFA
TEAS REQUEST FOR RECONSIDERATION RECEIVED
Mar 18, 2013 ERFR
NOTIFICATION OF ACTION DENYING REQ FOR RECON E-MAILED
Jan 22, 2013 GEA1
ACTION DENYING REQ FOR RECON E-MAILED
Jan 22, 2013 GECD
ACTION CONTINUING FINAL - COMPLETED
Jan 22, 2013 CNCF
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Nov 24, 2012 OPNX
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Nov 20, 2012 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Nov 20, 2012 REAP
JURISDICTION RESTORED TO EXAMINING ATTORNEY
Nov 20, 2012 JURT
TEAS/EMAIL CORRESPONDENCE ENTERED
Nov 20, 2012 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Nov 20, 2012 CRFA
TEAS REQUEST FOR RECONSIDERATION RECEIVED
Nov 16, 2012 ERFR
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Nov 7, 2012 OPNS
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Nov 7, 2012 OPNR
NOTIFICATION OF SUBSEQUENT FINAL EMAILED
Aug 8, 2012 GNS1
SUBSEQUENT FINAL EMAILED
Aug 8, 2012 GNSF
SUBSEQUENT FINAL REFUSAL WRITTEN
Aug 8, 2012 CFRC
TEAS/EMAIL CORRESPONDENCE ENTERED
Jul 19, 2012 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jul 19, 2012 CRFA
ASSIGNED TO LIE
Jul 13, 2012 ALIE
TEAS REQUEST FOR RECONSIDERATION RECEIVED
Jul 9, 2012 ERFR
EX PARTE APPEAL-INSTITUTED
Jul 9, 2012 EXPI
JURISDICTION RESTORED TO EXAMINING ATTORNEY
Jul 9, 2012 JURT
EXPARTE APPEAL RECEIVED AT TTAB
Jul 9, 2012 EXAF
NOTIFICATION OF FINAL REFUSAL EMAILED
Jan 9, 2012 GNFN
FINAL REFUSAL E-MAILED
Jan 9, 2012 GNFR
FINAL REFUSAL WRITTEN
Jan 9, 2012 CNFR
TEAS/EMAIL CORRESPONDENCE ENTERED
Dec 12, 2011 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Dec 12, 2011 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Dec 12, 2011 TROA
REFUSAL PROCESSED BY IB
Jul 4, 2011 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Jun 13, 2011 RFCS
REFUSAL PROCESSED BY MPU
Jun 13, 2011 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Jun 11, 2011 RFCR
NON-FINAL ACTION WRITTEN
Jun 10, 2011 CNRT
APPLICATION FILING RECEIPT MAILED
Jun 7, 2011 MAFR
ASSIGNED TO EXAMINER
Jun 3, 2011 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jun 3, 2011 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Jun 2, 2011 REPR